The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis.
about
Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolitesRetrospective analysis of bendamustine and rituximab use in indolent and mantle cell non-Hodgkin lymphoma based on initial starting dose.Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia.Bendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose?
P2860
The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The safety of bendamustine in ...... ical record database analysis.
@ast
The safety of bendamustine in ...... ical record database analysis.
@en
type
label
The safety of bendamustine in ...... ical record database analysis.
@ast
The safety of bendamustine in ...... ical record database analysis.
@en
prefLabel
The safety of bendamustine in ...... ical record database analysis.
@ast
The safety of bendamustine in ...... ical record database analysis.
@en
P2093
P2860
P1433
P1476
The safety of bendamustine in ...... ical record database analysis.
@en
P2093
Beth L Nordstrom
Dana Y Teltsch
Hooman Beygi
James A Sterchele
Kevin B Knopf
Robert Engle
P2860
P304
P356
10.3109/10428194.2013.836600
P577
2013-10-03T00:00:00Z